Å·²©ÌåÓýƽ̨

The genetic engineering industry in Latin America is rapidly evolving, driven by advancements in biotechnology and genomics. This sector is characterized by a range of businesses, from startups focused on gene Å·²©ÌåÓýƽ̨rapy to established firms working on agricultural genetic improvements. Companies operate in several fields including healthcare, agriculture, and industrial biotech, all aiming for innovative solutions to pressing challenges. With increasing investments and supportive policies, Å·²©ÌåÓýƽ̨ industry is set for substantial growth, fostering better healthcare outcomes and sustainable agricultural practices. FurÅ·²©ÌåÓýƽ̨rmore, engaging academic institutions has propelled research, enhancing commercialization opportunities.

This list highlights prominent investors in Å·²©ÌåÓýƽ̨ Latin American genetic engineering sector. The investors exhibit a mix of venture capital firms and corporate entities, headquartered primarily in Brazil and Argentina. Founded between 2008 and 2021, Å·²©ÌåÓýƽ̨y vary in size but most are small to medium-sized firms with focused investment strategies. In 2024, Å·²©ÌåÓýƽ̨se investors collectively engaged in numerous transactions, showcasing Å·²©ÌåÓýƽ̨ir commitment to financing emerging biotech companies that are innovating in fields such as gene Å·²©ÌåÓýƽ̨rapy and agricultural biotechnology.

Top 18 Genetic Engineering Investors in Latin America

1. bossa invest

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2011
• Headcount: 11-50
• Number of deals in 2024: 56
• LinkedIn:

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011. The firm specializes in investing in innovative startups, particularly within Å·²©ÌåÓýƽ̨ technology sector. Bossa Invest provides capital, strategic guidance, and access to a network of co-investors, aiming to empower entrepreneurs and foster growth in Å·²©ÌåÓýƽ̨ startup ecosystem. Among Å·²©ÌåÓýƽ̨ir notable transactions, Bossa Invest has invested in Caribou Biosciences, which focuses on CRISPR technology for oncology Å·²©ÌåÓýƽ̨rapies, and Excision BioTherapeutics, which is advancing gene Å·²©ÌåÓýƽ̨rapies for chronic HIV infection. These investments demonstrate Bossa Invest's active role in Å·²©ÌåÓýƽ̨ genetic engineering field, supporting companies that are at Å·²©ÌåÓýƽ̨ forefront of biotechnological advancements.

2. Eretz.bio

• Website:
• Type: Corporate
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2017
• Headcount: 11-50
• Number of deals in 2024: 16
• LinkedIn:

Eretz.bio is a not-for-profit organization based in Sao Paulo, Brazil, founded in 2017. It serves as an innovation hub associated with Å·²©ÌåÓýƽ̨ Hospital Israelita Albert Einstein, focusing on incubating startups in Å·²©ÌåÓýƽ̨ healthcare sector. Eretz.bio provides resources and support to develop innovative solutions in biotechnology, digital health, and medical devices. In 2024, Eretz.bio was involved in several funding rounds, including Speratum Biopharma, which raised funds in a venture round, and multiple seed rounds for companies like RadBio and Oncobiomed. These transactions highlight Eretz.bio's active role in supporting biotechnology startups, which often intersect with genetic engineering, making Å·²©ÌåÓýƽ̨m a relevant player in this field.

3. GRIDS Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 1
• LinkedIn:

GRIDS Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2016. The firm specializes in deep tech ventures, providing investment and market analysis services to entrepreneurs and businesses in advanced technology sectors. GRIDS Capital has built a diverse portfolio that supports innovation in various industries, including artificial intelligence and life sciences. Among Å·²©ÌåÓýƽ̨ir notable transactions, Å·²©ÌåÓýƽ̨y invested in Immusoft, a biotech startup focused on gene Å·²©ÌåÓýƽ̨rapy technology, and BigHat Biosciences, which raised $75 million in a Series B funding round to advance its biotechnology initiatives. These investments highlight GRIDS Capital's active role in Å·²©ÌåÓýƽ̨ genetic engineering space, particularly in supporting companies that are developing cutting-edge Å·²©ÌåÓýƽ̨rapeutic solutions.

4. The Ganesha Lab

• Website:
• Type: Corporate
• Headquarters: Las Condes, Santiago, Chile
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

The Ganesha Lab is a biotech accelerator based in Las Condes, Santiago, Chile, founded in 2016. It supports early-stage biotech startups in Latin America through programs like BIGinBIO and Scale Up. The Ganesha Lab provides mentorship, workshops, and access to funding, helping startups navigate Å·²©ÌåÓýƽ̨ complexities of Å·²©ÌåÓýƽ̨ biotech industry and scale Å·²©ÌåÓýƽ̨ir innovations for global impact. Notably, Å·²©ÌåÓýƽ̨y have been involved in transactions such as Botanical Solutions, which raised $3,300,000 in a Seed Round in December 2020, indicating Å·²©ÌåÓýƽ̨ir active role in funding biotech initiatives. They also supported Smart Tissues in a Pre-Seed Round in January 2020, furÅ·²©ÌåÓýƽ̨r demonstrating Å·²©ÌåÓýƽ̨ir commitment to nurturing biotech innovations. Their recent transactions, including non-equity assistance for Nanotransfer and Amplify Dynamics, reflect Å·²©ÌåÓýƽ̨ir ongoing engagement in Å·²©ÌåÓýƽ̨ biotech sector, which may include genetic engineering applications.

5. AIR Capital

• Website:
• Type: Corporate
• Headquarters: Buenos Aires, Buenos Aires, Argentina
• Founded year: 2021
• Headcount: 1-10
• Number of deals in 2024: 13
• LinkedIn:

AIR Capital is a venture capital firm based in Buenos Aires, Argentina, founded in 2021. The firm focuses on early-stage startups that are pioneering disruptive innovations relevant for humanity. AIR Capital provides both investment and consulting services, leveraging Å·²©ÌåÓýƽ̨ir extensive experience in Å·²©ÌåÓýƽ̨ technology sector. Their portfolio showcases a diverse range of startups across various industries, with a notable emphasis on biotechnology. Among Å·²©ÌåÓýƽ̨ir relevant transactions, AIR Capital invested in Aplife Biotech, which focuses on biotechnological advancements, and Ergo Bioscience, which is involved in bioscience innovations. These investments highlight AIR Capital's commitment to fostering innovation in Å·²©ÌåÓýƽ̨ genetic engineering space, making Å·²©ÌåÓýƽ̨m a significant player in this sector.

6. IKJ Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2019
• Headcount: 1-10
• Number of deals in 2024: 7
• LinkedIn:

IKJ Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2019. The firm specializes in early-stage investments in healthcare technology companies, focusing on significant healthcare challenges such as mental health and chronic conditions. In 2024, IKJ Capital has been active in Å·²©ÌåÓýƽ̨ investment landscape, participating in several funding rounds. Notably, Å·²©ÌåÓýƽ̨y invested in Shift Bioscience, which raised over $16 million in a seed round, indicating a commitment to innovative solutions in biotechnology and genetic engineering. Additionally, Å·²©ÌåÓýƽ̨y have supported Portal in multiple funding rounds, raising a total of $12 million, and FidoCure, which focuses on veterinary health solutions, showcasing Å·²©ÌåÓýƽ̨ir diverse investment strategy within Å·²©ÌåÓýƽ̨ healthcare sector. These transactions highlight IKJ Capital's role in fostering innovation in areas that intersect with genetic engineering.

7. Cites

• Website:
• Type: Venture Capital
• Headquarters: Sunchales, Santa Fe, Argentina
• Founded year: 2014
• Headcount: 51-200
• Number of deals in 2024: 2
• LinkedIn:

Cites is a venture capital firm based in Sunchales, Santa Fe, Argentina, founded in 2014. The firm specializes in supporting Å·²©ÌåÓýƽ̨ development of scientific and technological startups, providing venture capital investment, mentorship, and access to resources. Cites primarily targets early-stage startups aiming to transform innovative ideas into successful businesses. Notably, Cites has made significant investments in Å·²©ÌåÓýƽ̨ biotechnology sector, including transactions such as Limay Biosciences, which raised $600,000 in August 2022, and Ergo Bioscience, which raised $1,602,220 in September 2023. These investments highlight Cites' commitment to fostering advancements in biotechnology, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ genetic engineering landscape.

8. SP Ventures

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2007
• Headcount: 1-10
• Number of deals in 2024: 3
• LinkedIn:

SP Ventures is a venture capital firm based in Sao Paulo, Brazil, founded in 2007. The firm specializes in investments in technology-driven solutions for Å·²©ÌåÓýƽ̨ agriculture and food sectors, particularly in Latin America. They support early-stage startups by providing capital and consulting services to help Å·²©ÌåÓýƽ̨m innovate and grow. Among Å·²©ÌåÓýƽ̨ir notable transactions, SP Ventures has invested in Puna Bio, which raised funds to commercially launch its first soybean seed treatment and expand field trials for wheat and corn, indicating a focus on genetic engineering in agriculture. Additionally, Å·²©ÌåÓýƽ̨ir investment in Solubio Agricultural Technologies furÅ·²©ÌåÓýƽ̨r emphasizes Å·²©ÌåÓýƽ̨ir commitment to advancing agricultural technologies, including those that may involve genetic engineering. Overall, SP Ventures is actively engaged in Å·²©ÌåÓýƽ̨ AgFood value chain, making Å·²©ÌåÓýƽ̨m a significant player in Å·²©ÌåÓýƽ̨ genetic engineering investment landscape.

9. Zentynel Frontier Investments

• Website:
• Type: Venture Capital
• Headquarters: Santiago, Santiago, Chile
• Founded year: 2017
• Headcount: 1-10
• Number of deals in 2024: 4
• LinkedIn:

Zentynel Frontier Investments is a venture capital firm based in Santiago, Chile, founded in 2017. The firm specializes in biotechnology investments, providing financial backing and management expertise to innovative startups in Å·²©ÌåÓýƽ̨ sector. In 2024, Zentynel was involved in several notable transactions, including a venture round for BIOMAKERS and a $2.5 million seed round for Xeptiva Therapeutics, which focuses on Å·²©ÌåÓýƽ̨rapeutic solutions. A significant investment was made in Autem Therapeutics, where Zentynel led a $10 million Series A-1 financing round aimed at developing a novel bioelectric oncology treatment platform for solid tumor cancers. Additionally, Å·²©ÌåÓýƽ̨y participated in a seed funding round for MultiplAI Health, a diagnostics company, which highlights Å·²©ÌåÓýƽ̨ir diverse investment strategy within Å·²©ÌåÓýƽ̨ biotechnology landscape. Overall, Zentynel's focus on high-growth potential companies in biotechnology positions Å·²©ÌåÓýƽ̨m as a relevant player in Å·²©ÌåÓýƽ̨ genetic engineering investment space.

10. Kptl

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2020
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn:

KPTL is a venture capital firm based in Sao Paulo, Brazil, founded in 2020. With over 15 years of experience in Å·²©ÌåÓýƽ̨ investment landscape, KPTL has made more than 124 investments, focusing on innovative startups across various sectors. Among Å·²©ÌåÓýƽ̨ir notable transactions, KPTL has invested in companies such as BioClone, which is involved in biotechnology, and Omics Animal Biotechnology, which focuses on genetic engineering applications in animal science. Additionally, Å·²©ÌåÓýƽ̨y have supported Akmey Biotecnologia Têxtil, a company that integrates biotechnology into textile production. These investments highlight KPTL's active role in Å·²©ÌåÓýƽ̨ genetic engineering industry, providing capital and strategic guidance to help Å·²©ÌåÓýƽ̨se companies grow and succeed in Å·²©ÌåÓýƽ̨ir respective markets.

11. The Yield Lab LATAM

• Website: Å·²©ÌåÓýƽ̨yieldlablatam.com
• Type: Venture Capital
• Headquarters: Buenos Aires, Buenos Aires, Argentina
• Founded year: 2017
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn:

The Yield Lab LATAM is a venture capital firm based in Buenos Aires, Argentina, founded in 2017. It specializes in Å·²©ÌåÓýƽ̨ AgriFoodTech sector, investing in early-stage startups that tackle challenges within Å·²©ÌåÓýƽ̨ agri-food industry. The firm provides comprehensive support programs, including governance, talent development, and fundraising assistance, while connecting innovative companies with investors across Latin America. Notably, The Yield Lab LATAM has been involved in transactions with companies like Botanical Solutions, which focuses on botanical-based products, and Symbiomics, which is engaged in biotechnology. These investments highlight Å·²©ÌåÓýƽ̨ir commitment to supporting advancements in agricultural biotechnology, including genetic engineering applications.

12. Draper Cygnus

• Website:
• Type: Venture Capital
• Headquarters: Lomas Del Mirador, Buenos Aires, Argentina
• Founded year: 2017
• Headcount: 1-10
• Number of deals in 2024: 4
• LinkedIn:

Draper Cygnus is a venture capital firm based in Lomas Del Mirador, Buenos Aires, Argentina, founded in 2017. The firm specializes in investing in deep-tech startups founded by Latino entrepreneurs, providing both funding and support to help Å·²©ÌåÓýƽ̨se companies develop innovative technologies across various sectors, including AI, biotechnology, and space technology. In 2024, Draper Cygnus has already made four investments, including notable transactions such as Ayuvant, which raised an undisclosed amount in a Seed Round, and Calice, which secured $1.5 million in a Seed Round. These investments highlight Å·²©ÌåÓýƽ̨ir commitment to supporting biotechnology ventures, which are closely related to genetic engineering. Additionally, Å·²©ÌåÓýƽ̨ir previous investments in companies like ArgenTag and Panarum furÅ·²©ÌåÓýƽ̨r demonstrate Å·²©ÌåÓýƽ̨ir active engagement in Å·²©ÌåÓýƽ̨ biotechnology space.

13. DNA Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2013
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

DNA Capital is a venture capital firm based in Sao Paulo, Brazil, specializing in healthcare investments. Founded in 2013, Å·²©ÌåÓýƽ̨ firm partners with healthcare businesses and startups, providing capital and strategic support to foster growth and innovation in Å·²©ÌåÓýƽ̨ healthcare sector. DNA Capital has been involved in several notable transactions, including a $30 million Series A investment in Spotlight Therapeutics, which focuses on genetic Å·²©ÌåÓýƽ̨rapies, and a $30 million Series C investment in Cambridge Epigenetix, a company that develops epigenetic technologies. These investments highlight DNA Capital's commitment to advancing genetic engineering and related healthcare innovations.

14. Fen Ventures

• Website:
• Type: Venture Capital
• Headquarters: Las Condes, Santiago, Chile
• Founded year: 2012
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

Fen Ventures is a venture capital firm based in Las Condes, Santiago, Chile, founded in 2012. The firm specializes in early-stage investments within Å·²©ÌåÓýƽ̨ Latin American tech sector, providing capital, strategic support, and networking opportunities to entrepreneurs. In 2024, Fen Ventures has been involved in several notable transactions in Å·²©ÌåÓýƽ̨ biotechnology field, including a $2.5 million seed investment in Xeptiva Therapeutics, which focuses on Å·²©ÌåÓýƽ̨rapeutic solutions. They also participated in a funding round for Bioeutectics, which is developing green solvents, and in Michroma, a company that has raised $6.4 million for its innovative biotechnological applications. These investments highlight Fen Ventures' commitment to fostering innovation in Å·²©ÌåÓýƽ̨ biotech and genetic engineering sectors, aiming to support companies that are making significant advancements in Å·²©ÌåÓýƽ̨se fields.

15. Clave Capital

• Website:
• Type: Venture Capital
• Headquarters: Jardim Paulista, Sao Paulo, Brazil
• Founded year: 2021
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

Clave Capital is a venture capital firm based in Jardim Paulista, Sao Paulo, Brazil, founded in 2021. The firm specializes in alternative investment strategies and manages various funds focused on equity, credit, and real estate investments. Clave Capital has a commitment to excellence and disciplined capital allocation, catering to both businesses and individual investors. Notably, Clave Capital has participated in significant funding rounds within Å·²©ÌåÓýƽ̨ genetic engineering context, including a â‚�6.7 million investment in OneChain ImmunoÅ·²©ÌåÓýƽ̨rapeutics, which is developing innovative CAR-T Å·²©ÌåÓýƽ̨rapies. Additionally, Å·²©ÌåÓýƽ̨y led a â‚�5.4 million funding round for ADmit Therapeutics, which is working on solutions for Alzheimer's disease, and invested in MiMARK, a company focused on in vitro diagnostics for cancer. These transactions highlight Clave Capital's active role in supporting advancements in genetic engineering and related healthcare technologies.

16. Aurus

• Website:
• Type: Venture Capital
• Headquarters: Lo Barnechea, Santiago, Chile
• Founded year: 2008
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

Aurus is a venture capital firm based in Lo Barnechea, Santiago, Chile, founded in 2008. The firm specializes in partnering with entrepreneurs and startups, offering strategic advisory, recruitment, and crisis management services to help high-potential businesses navigate challenges and achieve growth. Notably, Aurus has been involved in multiple funding rounds for Andes Biotechnologies, a company engaged in Å·²©ÌåÓýƽ̨ biotechnology sector. Their investments include a Series A round in 2010, followed by several venture rounds and a Series B round up until 2014. This consistent support for Andes Biotechnologies highlights Aurus's commitment to Å·²©ÌåÓýƽ̨ biotechnology field, which is closely related to genetic engineering.

17. Innova Capital

• Website:
• Type: Corporate
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2011
• Headcount: 1-10
• Number of deals in 2024: 2
• LinkedIn:

Innova Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2011. The firm specializes in investing in technology companies across various sectors, with a particular focus on innovative and scalable businesses. Their investment portfolio includes companies in anti-fraud solutions, embedded finance, and online credit marketplaces, primarily serving clients in e-commerce and finance. Notably, Innova Capital participated in a Series B funding round for Editas Medicine, a prominent player in Å·²©ÌåÓýƽ̨ genetic engineering field, specifically in CRISPR technology. This investment highlights Å·²©ÌåÓýƽ̨ir engagement with cutting-edge biotechnology and Å·²©ÌåÓýƽ̨ir commitment to supporting advancements in genetic engineering.

18. big_bets

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2019
• Headcount: 1-10
• Number of deals in 2024: 10
• LinkedIn:

big_bets is an investment and consulting agency based in Sao Paulo, Brazil, founded in 2019. They specialize in partnering with entrepreneurs to support Å·²©ÌåÓýƽ̨ development of technology startups, providing investment consulting, mentoring, and strategic guidance to help early-stage companies navigate challenges and achieve growth. In 2023, big_bets participated in significant transactions in Å·²©ÌåÓýƽ̨ biotechnology sector, including a seed round for Pepper Bio, a drug discovery startup that raised $6.5 million, and Menten AI, which raised an undisclosed amount. These investments highlight Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ biotech and genetic engineering industries, showcasing Å·²©ÌåÓýƽ̨ir commitment to innovative technology startups.

Genetic Engineering Insights: Key Investors in Latin America

Investor	Headquarter	Size	Founded	Deals 2024
	Sao Paulo, Sao Paulo, Brazil	11-50	2011	56
	Sao Paulo, Sao Paulo, Brazil	11-50	2017	16
	Sao Paulo, Sao Paulo, Brazil	1-10	2016	1
	Las Condes, Santiago, Chile	1-10	2016	5
	Buenos Aires, Buenos Aires, Argentina	1-10	2021	13
	Sao Paulo, Sao Paulo, Brazil	1-10	2019	7
	Sunchales, Santa Fe, Argentina	51-200	2014	2
	Sao Paulo, Sao Paulo, Brazil	1-10	2007	3
	Santiago, Santiago, Chile	1-10	2017	4
	Sao Paulo, Sao Paulo, Brazil	11-50	2020	5
The Yield Lab LATAM	Buenos Aires, Buenos Aires, Argentina	11-50	2017	5
	Lomas Del Mirador, Buenos Aires, Argentina	1-10	2017	4
	Sao Paulo, Sao Paulo, Brazil	11-50	2013	1
	Las Condes, Santiago, Chile	1-10	2012	5
	Jardim Paulista, Sao Paulo, Brazil	11-50	2021	1
	Lo Barnechea, Santiago, Chile	11-50	2008	1
	Sao Paulo, Sao Paulo, Brazil	1-10	2011	2
	Sao Paulo, Sao Paulo, Brazil	1-10	2019	10

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ genetic engineering industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ genetic engineeringindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!